Neuland Laboratories Ltd completes USFDA inspection at Unit 2

The United States Food and Drug Administration ("US FDA") has inspected Neuland Laboratories Limited's Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, from April 28, 2025 to May 2, 2025.

The FDA issued Form 483, with one observation related to building and facility management, which the company will respond to within the stipulated timelines.

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 11942.40 as compared to the previous close of Rs. 12036.90. The total number of shares traded during the day was 2462 in over 727 trades.

The stock hit an intraday high of Rs. 12198.95 and intraday low of 11750.00. The net turnover during the day was Rs. 29343074.00.

Source : Equity Bulls

Keywords

NeulandLaboratories INE794A01010 Pharmaceuticals USFDA Inspection Unit2 Form483 OneObservation